Integral Capital Partners
About Us
Our Strategy
Our Team
Contact Us portfolio/category.php3

Our Portfolio
Private Portfolio
Top 10 Holdings
Fund History

The Integral Experience
What CEOs Say

In The News
Integral News
Portfolio News
Search the News


Our PortfolioPrivate Portfolio

Industry Sector: Life Sciences

20 Companies
Pages [ 1 2 , Prev, Next ]
Display text only
Company  
Current Portfolio
Access Closure
Synthetic Wound-Healing Hydrogel Designed to Seal Artery Punctures After Endovascular Procedures
Access Closure


Aragon Surgical
Electrosurgical Instruments and Laparoscopic Enabling Tools
Aragon Surgical


Evalve
Devices to Enable Percutaneous Repair of Cardiac Valves
Evalve


Genomic Health (GHDX)
Diagnostic Services Based on Genomic Analysis
Genomic Health


NeuroPace
Market Implantable Devices for the Treatment of Neurological Disorders by Responsive Brain Stimulation
NeuroPace


TherOx
Aqueous Oxygen Systems for the Minimally Invasive Treatment of Cardiovascular Disease
TherOx


Vapotherm
Respiratory Devices with High Flow Delivery
Vapotherm


XDx
Molecular Diagnostics for Post-Cardiac Transplant Patient Management
XDx


Former Portfolio
Argonaut Technologies (AGNT)
Organic Synthesizers, Software and Chemical Resins and Reagents for Solution-Phase and Solid-Phase Chemistry
Argonaut Technologies


Axion Pharmaceuticals (BMY)
Drug Distribution to Oncologists

Acquired by Bristol-Myers Squibb
Bristol-Myers Squibb


20 Companies
Pages [ 1 2 , Prev, Next ]

View By
 
Industry Sector
  Application Software
  Consumer Software
  Internet Services
  Life Sciences
  Networking/Infrastructure Equipment
  Semiconductors & Components
  Infrastructure Software
  Telecom Services
  Outsourced Services
By Fund
  Integral I
  Integral II
  Integral III
  Integral IV
  Integral V
  Integral VI
  Integral VII
  Integral VIII

All Alphabetically

 
   
Home | About Us | Our Portfolio | The Integral Experience | In The News | Contact Us

3000 Sand Hill Road, Building 3, Suite 240
Menlo Park, California 94025
© 2000 Integral Capital Partners